Treatment.Com International Inc. (TREIF)
USD 0.37
(0.0%)
USD 0.37
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -740.07 Thousand | -1.45 Million | -6.29 Million | -2.01 Million | -509.7 Thousand | -107.43 Thousand |
| Net Income | -3.72 Million | -3.79 Million | -13.86 Million | -2.9 Million | -3 Million | -70.08 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 579.3 Thousand | 1.42 Million | 6.99 Million | 464.94 Thousand | - | - |
| Change in working capital | 827.64 Thousand | 817.96 Thousand | 230.95 Thousand | 410.61 Thousand | 162.65 Thousand | -37.35 Thousand |
| Other non-cash items | 2.17 Million | 93.44 Thousand | 351.79 Thousand | 20.54 Thousand | 2.33 Million | 38.34 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.45 Million | 540.62 Thousand | 6.94 Million | 1.85 Million | 1 Million | 120.66 Thousand |
| Debt repayment | -99.48 Thousand | -340.55 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.35 Million | - | 6.82 Million | 1.85 Million | 1 Million | 120.66 Thousand |
| Other Financing Activities | 99.48 Thousand | 881.17 Thousand | 120 Thousand | 1.85 Million | 1025.00 | 120.66 Thousand |
| Accounts receivables | -16.51 Thousand | -46.00 | -125.00 | -560.00 | 38.34 Thousand | -38.34 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 844.16 Thousand | 818.01 Thousand | 231.07 Thousand | 411.17 Thousand | 124.31 Thousand | 987.00 |
| Cash at beginning of period | 2495.00 | 916.75 Thousand | 312.64 Thousand | 515.39 Thousand | 25.17 Thousand | 11.02 Thousand |
| Cash at end of period | 715.52 Thousand | 2495.00 | 916.75 Thousand | 312.64 Thousand | 515.39 Thousand | 25.17 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -125.00 | 3231.00 | -47.32 Thousand | -46.61 Thousand | -1100.00 | - |
| Net cash flow / Change in cash | 713.03 Thousand | -914.25 Thousand | 604.1 Thousand | -202.75 Thousand | 490.21 Thousand | 14.15 Thousand |
| Free Cash Flow | -740.07 Thousand | -1.45 Million | -6.29 Million | -2.01 Million | -509.7 Thousand | -107.43 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.71 Million | -926.64 Thousand | -2.21 Million | -3.72 Million | -836.18 Thousand | -288.07 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 442.48 Thousand | 391.3 Thousand | 377.74 Thousand | 579.3 Thousand | 59.15 Thousand | 71.2 Thousand |
| Change in working capital | -60.11 Thousand | -324.73 Thousand | -300.93 Thousand | 827.64 Thousand | 734.53 Thousand | 147.89 Thousand |
| Other non-cash items | 1.4 Million | 393.86 Thousand | 1.86 Million | 2.17 Million | 46.76 Thousand | 20.2 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 5353.00 | 2.43 Million | 469.48 Thousand | 1.45 Million | 901.58 Thousand | 33.51 Thousand |
| Debt repayment | -254.00 | -42.57 Thousand | -113.23 Thousand | -99.48 Thousand | -95.91 Thousand | -33.51 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 5099.00 | 2.48 Million | 356.25 Thousand | 1.35 Million | 997.5 Thousand | - |
| Other Financing Activities | 254.00 | -52.57 Thousand | 113.23 Thousand | 99.48 Thousand | -95.91 Thousand | 33.51 Thousand |
| Accounts receivables | 10.73 Thousand | 16.51 Thousand | 383.00 | -16.51 Thousand | -16.91 Thousand | 16.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -70.84 Thousand | -341.25 Thousand | -301.31 Thousand | 844.16 Thousand | 751.45 Thousand | 147.87 Thousand |
| Cash at beginning of period | 2.3 Million | 715.52 Thousand | 897.39 Thousand | 2495.00 | 474.00 | 7030.00 |
| Cash at end of period | 944.84 Thousand | 2.3 Million | 715.52 Thousand | 715.52 Thousand | 897.39 Thousand | 474.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -3213.00 | -4477.00 | 207.00 | -125.00 | -8939.00 | 8699.00 |
| Net cash flow / Change in cash | -1.35 Million | 1.58 Million | -181.86 Thousand | 713.03 Thousand | 896.91 Thousand | -6556.00 |
| Free Cash Flow | -1.36 Million | -840.99 Thousand | -651.55 Thousand | -740.07 Thousand | 4276.00 | -48.76 Thousand |
JOG
SHRS
PGHH
NG
3523
8999